← All stories
Markets
Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce t…
Covered by 1 outlet
All coverage · 1 article